China CDC Recommends Flu Shots for All Ages 6 Months and Up

This is a public health directive, not a market event, so its significance lies in potential downstream effects on vaccine supply chains and regional healthcare logistics. The broad age range signals an expectation of high seasonal influenza circulation, which could strain health systems and affect workforce productivity. For markets, the open question is whether this recommendation translates into increased procurement or manufacturing focus for trivalent vaccines in China, and how that impacts global flu vaccine availability. No direct crypto or RWA angle is present, so the take is limited to macro health-system implications.